<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>RSS</title>
    <link>http://www.orion.fi/</link>
    <description>
    </description>
    <item>
      <title>Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2012 AGM of Orion Corporation</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/16/3/</link>
      <description>Orion Corporation&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; Stock Exchange Release&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; 30 January 2012&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; at 12.35&amp;nbsp; EET The Nomination Committee of Orion Corporation has given on 30 January 2012 its recommendation to the Board of Directors of the company for the proposal to the Annual General Meeting of 2012 concerning the composition of the Board of Directors to be elected. The Committee recommends that the following...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/16/3/</guid>
      <pubDate>Mon, 30 Jan 2012 12:42:41 GMT</pubDate>
    </item>
    <item>
      <title>Orion Corporation: Annual Summary of Stock Exchange Releases published in 2011</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/16/2/</link>
      <description>ORION CORPORATION&amp;nbsp; STOCK EXCHANGE RELEASE 20 JAN 2012 AT 9.30 EET &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; In accordance with Chapter 2, Section 10 c of the Finnish Securities Market Act, Orion Corporation publishes an Annual Summary of the stock exchange releases published by the company in 2011. The releases are available on the internet website of Orion Corporation, at http:// www.orion.fi/sereleases . Orion points ou...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/16/2/</guid>
      <pubDate>Fri, 20 Jan 2012 09:31:53 GMT</pubDate>
    </item>
    <item>
      <title>Orion invites analysts and media to Financial Statement Release conference on Tuesday 7 February 2012</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/16/1/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE&amp;nbsp;20&amp;nbsp;JANUARY 2012 at 8.00 AM&amp;nbsp; EET Orion will publish its Financial Statement Release for 2011 on Tuesday, 7 February 2012 approximately at 12:00 Finnish time (EET). The release and related presentation material in Finnish and in English will be available on the Group's homepage at www.orion.fi/en promptly after the publishing. News conference for analysts...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/16/1/</guid>
      <pubDate>Fri, 20 Jan 2012 08:02:41 GMT</pubDate>
    </item>
    <item>
      <title>Production restarts at Orion’s manufacturing plant in Turku after the fire in November </title>
      <link>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/2011/Production-restarts-at-Orions-manufacturing-plant-in-Turku-after-the-fire-in-November-/</link>
      <description>Production at Orion’s manufacturing plant in Turku has restarted after the fire that took place in November. The interruption in production was shorter than initially estimated. The start-up of production lines is underway in many of the departments at the manufacturing plant and the majority of the plant’s production lines are already up and running or at the start-up phase. The preparations f...</description>
      <guid>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/2011/Production-restarts-at-Orions-manufacturing-plant-in-Turku-after-the-fire-in-November-/</guid>
      <pubDate>Wed, 21 Dec 2011 09:53:09 GMT</pubDate>
    </item>
    <item>
      <title>Orion Corporation: 201,000 Orion A-shares converted into B-shares</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/35/</link>
      <description>ORION CORPORATION&amp;nbsp; STOCK EXCHANGE RELEASE&amp;nbsp; 20&amp;nbsp;December 2011&amp;nbsp; AT 8.40 AM EET In accordance with Section 3 of the Articles of Association of Orion Corporation, 201,000 A-shares have been converted into 201,000&amp;nbsp; B-shares. The conversion has been entered into the Trade Register on&amp;nbsp;20&amp;nbsp;December 2011. The total number of shares in Orion Corporation is 141,257,828&amp;nbsp; which, after the conversion, consists...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/35/</guid>
      <pubDate>Tue, 20 Dec 2011 08:42:01 GMT</pubDate>
    </item>
    <item>
      <title>Fire stops production at Orion's manufacturing plant in Turku</title>
      <link>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/2011/Fire-stops-production-at-Orions-manufacturing-plant-in-Turku/</link>
      <description>PRESS RELEASE&amp;nbsp;&amp;nbsp; 22&amp;nbsp; November 2011&amp;nbsp; at 18.10 EET The fire that took place at Orion's manufacturing plant in Turku early in the morning on Tuesday 22 November 2011 was successfully extinguished.&amp;nbsp; Due to the fire the production of&amp;nbsp; the plant is stopped for the time being. Fire broke out in the basement of the plant and spread smoke to the production facilities and other parts of the building causi...</description>
      <guid>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/2011/Fire-stops-production-at-Orions-manufacturing-plant-in-Turku/</guid>
      <pubDate>Tue, 22 Nov 2011 18:55:18 GMT</pubDate>
    </item>
    <item>
      <title>Disclosure Under Chapter 2 Section 10 </title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/34/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 7 November 2011 at 12:40 EET Orion Corporation (business code 1999212-6) has received a disclosure under Chapter 2, Section 9 of the Securities Markets Act, according to which the total number of the voting rights of the Orion shares owned by Erkki Etola and a company controlled by him, has in consequence of the share conversion under the Articles of...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/34/</guid>
      <pubDate>Mon, 07 Nov 2011 12:41:33 GMT</pubDate>
    </item>
    <item>
      <title>53,428 Orion A-shares converted into B-shares</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/33/</link>
      <description>ORION CORPORATION&amp;nbsp; STOCK EXCHANGE RELEASE 7 November 2011 AT 8.30 EET In accordance with Section 3 of the Articles of Association of Orion Corporation, 53,428 A-shares have been converted into 53,428 B-shares. The conversion has been entered into the Trade Register on 7 November 2011. The total number of shares in Orion Corporation is 141,257,828&amp;nbsp; which, after the conversion, consists of...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/33/</guid>
      <pubDate>Mon, 07 Nov 2011 08:32:16 GMT</pubDate>
    </item>
    <item>
      <title>Orion and Endo nominated for Scrip Award</title>
      <link>http://www.orion.fi/en/News-and-media/Actual--page-list/Orion-and-Endo-nominated-for-Scrip-Award/</link>
      <description>The annual prestige Scrip Awards gala will take place tonight in London. The cooperation of Orion and North American Endo Pharmaceuticals is nominated for the “Best Partnership Alliance” Scrip Award 2011. The Scrip Awards is organized by Scrip World Pharmaceutical News. Dr. Reijo Salonen, Senior Vice President of Orion Corporation's Research and Development commented: “We are very pleased and...</description>
      <guid>http://www.orion.fi/en/News-and-media/Actual--page-list/Orion-and-Endo-nominated-for-Scrip-Award/</guid>
      <pubDate>Thu, 03 Nov 2011 11:33:50 GMT</pubDate>
    </item>
    <item>
      <title>Change in Orion Group Executive Management Board as of 1 January 2012 </title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/32/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE&amp;nbsp;25&amp;nbsp;October 2011 at 12.30&amp;nbsp; EEST Mr. Pekka Konsi, Senior Vice President responsible for the Supply Chain line function of the Orion Group and member of the Executive Management Board of the Orion Group will retire in the beginning of 2012 and will step aside from his current position as of 1 January 2012.&amp;nbsp; &amp;nbsp; Mrs. Virve Laitinen, M.Sc. (Tech.), MBA, current...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/32/</guid>
      <pubDate>Tue, 25 Oct 2011 12:32:03 GMT</pubDate>
    </item>
    <item>
      <title>Orion Group Interim Report January-September 2011</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/31/</link>
      <description>ORION CORPORATION / INTERIM REPORT / JANUARY-SEPTEMBER 2011 / 25 October 2011 at 12:00 noon EEST Orion's net sales for January-September 2011 totalled EUR 682 million (EUR 635 million for January-September 2010), up by 7% on the comparative period last year. Operating profit was EUR 223 (202) million.&amp;nbsp; Profit before taxes was EUR 222 (200) million.&amp;nbsp; Equity ratio was 64% (62%).&amp;nbsp; ROCE before taxe...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/31/</guid>
      <pubDate>Tue, 25 Oct 2011 12:02:11 GMT</pubDate>
    </item>
    <item>
      <title>Orion invites analysts and media to Q3 news conference on Tuesday 25 October 2011</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/30/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE&amp;nbsp;11&amp;nbsp;OCTOBER 2011 at 8.35 am&amp;nbsp; EEST Orion will publish its Interim Report January-September 2011 on Tuesday, 25 October 2011 approximately at 12:00 Finnish time (EEST). The release and related presentation material in Finnish and in English will be available on the Group's homepage at www.orion.fi/en promptly after the publishing. News conference for analys...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/30/</guid>
      <pubDate>Tue, 11 Oct 2011 08:37:03 GMT</pubDate>
    </item>
    <item>
      <title>Orion Corporation introduces new intensive care sedative Dexdor®</title>
      <link>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/2011/1/</link>
      <description>PRESS RELEASE&amp;nbsp;&amp;nbsp; 5 October 2011&amp;nbsp; at 10.00 EEST Orion Corporation (Nasdaq OMX Helsinki: ORNAV and ORNBV) announced today at the annual congress of the European Society of Intensive Care Medicine (ESICM) in Berlin that the company is launching its new intensive care sedative dexdor® (dexmedetomidine) . Orion received European centralised marketing authorisation for dexdor® in September and t he...</description>
      <guid>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/2011/1/</guid>
      <pubDate>Thu, 06 Oct 2011 10:42:08 GMT</pubDate>
    </item>
    <item>
      <title>Disclosure Under Chapter 2 Section 10 </title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/29/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE&amp;nbsp;26&amp;nbsp;SEPTEMBER 2011 at 1:25&amp;nbsp;PM EEST Orion Corporation (business code 1999212-6) has received a disclosure under Chapter 2, Section 9 of the Securities Markets Act, according to which the total number of Orion B shares owned by the mutual funds under&amp;nbsp;the management of Capital Research and Management Company, has on 22 September 2011 through trades in the...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/29/</guid>
      <pubDate>Mon, 26 Sep 2011 13:29:53 GMT</pubDate>
    </item>
    <item>
      <title>400,000 Orion A-shares converted into B-shares</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/28/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 23 September 2011 at 8.45 a.m. EEST In accordance with Section 3 of the Articles of Association of Orion Corporation, 400,000 A-shares have been converted into 400,000 B-shares. The conversion has been entered into the Trade Register on 23 September 2011. The total number of shares in Orion Corporation is 141,257,828 which, after the conversion, consists...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/28/</guid>
      <pubDate>Fri, 23 Sep 2011 08:49:04 GMT</pubDate>
    </item>
    <item>
      <title>Composition of the Nomination Committee of Orion Corporation </title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/27/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 21 September 2011 at 18.27&amp;nbsp; EEST The Board of Directors of Orion Corporation has elected the following persons to the Nomination Committee of the company: Kari Jussi Aho Matti Kavetvuo Timo Ritakallio Seppo Salonen Hannu Syrjänen Jukka Ylppö &amp;nbsp; Matti Kavetvuo was elected Chairman of the Committee. The Committee prepares and presents a recommendation to th...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/27/</guid>
      <pubDate>Wed, 21 Sep 2011 18:28:09 GMT</pubDate>
    </item>
    <item>
      <title>Orion receives European marketing authorisation for dexdor® </title>
      <link>http://www.orion.fi/en/News-and-media/Actual--page-list/Orion-receives-European-marketing-authorisation-for-dexdor-/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 21 September 2011 at 11.15&amp;nbsp; EEST Orion Corporation has received information that the European Commission has granted centralised marketing authorisation for dexdor® (dexmedetomidine) indicated for sedation of adult intensive care unit (ICU) patients requiring a sedation level not deeper than arousal in response to verbal stimulation (corresponding to...</description>
      <guid>http://www.orion.fi/en/News-and-media/Actual--page-list/Orion-receives-European-marketing-authorisation-for-dexdor-/</guid>
      <pubDate>Wed, 21 Sep 2011 15:26:44 GMT</pubDate>
    </item>
    <item>
      <title>Orion receives European marketing authorisation for dexdor® </title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/26/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 21 September 2011 at 11.15&amp;nbsp; EEST Orion Corporation has received information that the European Commission has granted centralised marketing authorisation for dexdor® (dexmedetomidine) indicated for sedation of adult intensive care unit (ICU) patients requiring a sedation level not deeper than arousal in response to verbal stimulation (corresponding to...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/26/</guid>
      <pubDate>Wed, 21 Sep 2011 11:19:53 GMT</pubDate>
    </item>
    <item>
      <title>400,000 Orion A-shares converted into B-shares</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/25/</link>
      <description>ORION CORPORATION&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; STOCK EXCHANGE RELEASE 14 SEPTEMBER 2011 at 8.25 a.m. EEST &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; In accordance with Section 3 of the Articles of Association of Orion Corporation, 400,000 A-shares have been converted into 400,000 B-shares. The conversion has been entered into the Trade Register on 14 September 2011. The total number of shares in Orion Corporation is 141,257,828 which, after the...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/25/</guid>
      <pubDate>Wed, 14 Sep 2011 08:29:53 GMT</pubDate>
    </item>
    <item>
      <title>136,231 Orion A-shares converted into B-shares</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/24/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 19 August 2011 at 9.00&amp;nbsp; EEST In accordance with Section 3 of the Articles of Association of Orion Corporation, 136,231 A-shares have been converted into 136,231 B-shares. The conversion has been entered into the Trade Register on 19 August 2011. The total number of shares in Orion Corporation is 141,257,828&amp;nbsp; which, after the conversion, consists of...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/24/</guid>
      <pubDate>Fri, 19 Aug 2011 09:04:26 GMT</pubDate>
    </item>
    <item>
      <title>Orion Group Q4/2011 result will be published on 7 February 2012</title>
      <link>http://www.orion.fi/en/Investors/News/Q22011/</link>
      <description>
      </description>
      <guid>http://www.orion.fi/en/Investors/News/Q22011/</guid>
      <pubDate>Tue, 24 Jan 2012 09:22:09 GMT</pubDate>
    </item>
    <item>
      <title>Orion Corporation and Nycomed to collaborate on Easyhaler® for asthma and COPD</title>
      <link>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/2011/Orion-Corporation-and-Nycomed-to-collaborate-on-Easyhaler-for-asthma-and-COPD/</link>
      <description>PRESS RELEASE 4 August 2011 at 10.00 EEST Orion Corporation (Nasdaq OMX Helsinki: ORNAV and ORNBV) announced today that it has entered into a collaboration agreement with Nycomed for the co-marketing of Easyhaler® combination products for the treatment of asthma and COPD in the major European countries and an exclusive license and distribution arrangement for the Middle East and North Africa...</description>
      <guid>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/2011/Orion-Corporation-and-Nycomed-to-collaborate-on-Easyhaler-for-asthma-and-COPD/</guid>
      <pubDate>Thu, 04 Aug 2011 10:44:33 GMT</pubDate>
    </item>
    <item>
      <title>Orion Diagnostica acquires new technology from the UK</title>
      <link>http://www.orion.fi/en/News-and-media/Actual--page-list/Orion-Diagnostica-acquires-new-technology-from-the-UK/</link>
      <description>On 22 July, Orion Diagnostica strengthened its research and product development base by acquiring new early-phase technology through purchasing all the shares of the&amp;nbsp;UK-based&amp;nbsp; technology company GeneForm Technologies Ltd. ”The acquired technology gives Orion Diagnostica new tools to build a further business arm. We especially strengthen our competitiveness in infectious disease diagnostics,” sa...</description>
      <guid>http://www.orion.fi/en/News-and-media/Actual--page-list/Orion-Diagnostica-acquires-new-technology-from-the-UK/</guid>
      <pubDate>Tue, 02 Aug 2011 13:26:59 GMT</pubDate>
    </item>
    <item>
      <title>Orion Group Interim Report January-June 2011</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/23/</link>
      <description>ORION CORPORATION / INTERIM REPORT JANUARY-JUNE 2 August 2011at 12:00 p.m. EEST Orion Group Interim Report January-June 2011 Orion's net sales for January-June 2011 totalled EUR 471 million (EUR 422 million for January-June 2010), up by 12% on the comparative period last year. &amp;nbsp; Operating profit was EUR 158 (131) million. Profit before taxes was EUR 158 (130) million. Equity ratio was 61% (59%)...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/23/</guid>
      <pubDate>Tue, 02 Aug 2011 12:04:54 GMT</pubDate>
    </item>
    <item>
      <title>Orion Corporation's publication schedules for financial reporting in 2012</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/22/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE&amp;nbsp;2&amp;nbsp;August 2011 at 11.15 EEST Orion Corporation will publish its financial result for 2011 on Tuesday, 7 February 2012. &amp;nbsp; The publication dates of the Interim Reports in 2012 are as follows: Interim Report 1 - 3/2012&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Tuesday, 24 April 2012 Interim Report 1 - 6/2012&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Tuesday, 31 July 2012 Interim Report 1 - 9/2012&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Tuesday, 23...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/22/</guid>
      <pubDate>Tue, 02 Aug 2011 11:19:53 GMT</pubDate>
    </item>
    <item>
      <title>Orion's dexdor® (dexmedetomidine) intensive  care sedative receives positive CHMP opinion</title>
      <link>http://www.orion.fi/en/News-and-media/Actual--page-list/Orions-dexdor-dexmedetomidine-intensive--care-sedative-receives-positive-CHMP-opinion/</link>
      <description>The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has issued a positive opinion recommending the granting of marketing authorisation for Orion's&amp;nbsp; dexdor ® (dexmedetomidine) intensive care sedative. Click here to read the Orion stock exchange release on the topic. Click here to read a summary of CHMP's positive opinion for dexdor®. </description>
      <guid>http://www.orion.fi/en/News-and-media/Actual--page-list/Orions-dexdor-dexmedetomidine-intensive--care-sedative-receives-positive-CHMP-opinion/</guid>
      <pubDate>Mon, 25 Jul 2011 09:47:28 GMT</pubDate>
    </item>
    <item>
      <title>Orion receives positive CHMP opinion for new intensive care sedative, dexdor® (dexmedetomidine) </title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/21/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 22 July 2011 at 10.55&amp;nbsp; EEST Orion Corporation has received information that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the granting of marketing authorisation for&amp;nbsp; dexdor ® (dexmedetomidine), a new intensive care sedative. The European Commission is expected ...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/21/</guid>
      <pubDate>Fri, 22 Jul 2011 10:59:20 GMT</pubDate>
    </item>
    <item>
      <title>Orion invites analysts and media to Q2 news conference on Tuesday 2 August 2011</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/20/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 18 JULY 2011 at 13.10 EEST Orion will publish its Interim Report January-June 2011 on Tuesday, 2 August 2011 approximately at 12:00 Finnish time (EEST). The release and related presentation material in Finnish and in English will be available on the Group's homepage at www.orion.fi/en promptly after the publishing. News conference for analysts and media ...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/20/</guid>
      <pubDate>Mon, 18 Jul 2011 13:14:57 GMT</pubDate>
    </item>
    <item>
      <title>Financial Reviews</title>
      <link>http://www.orion.fi/en/News-and-media/Financial-Reviews/</link>
      <description>&amp;nbsp; Report Publishing Release Slides Recording Interim Report Q1/2011 27 Apr 2011 (902 Kb) (914 Kb) webcast Interim Report Q2/2011 2 Aug 2011 (493 Kb) (762 Kb) webcast Interim Report Q3/2011 25 Oct 2011 (1022 Kb) (921 Kb) webcast &amp;nbsp; Related links: &amp;nbsp; Presentation materials &amp;nbsp; Annual Reports &amp;nbsp; </description>
      <guid>http://www.orion.fi/en/News-and-media/Financial-Reviews/</guid>
      <pubDate>Tue, 25 Oct 2011 13:06:42 GMT</pubDate>
    </item>
    <item>
      <title>Orion and Eisai into a marketing agreement in China</title>
      <link>http://www.orion.fi/en/News-and-media/Actual--page-list/Orion-and-Eisai-into-a-marketing-agreement-in-China/</link>
      <description>Orion and the Japanese-based Eisai Co., Ltd.&amp;nbsp; have announced a comprehensive marketing agreement concerning Orion’s breast cancer drug Fareston® (toremifene citrate) and Parkinson’s disease treatment Eldepryl® (selegiline hydrochloride). &amp;nbsp; Under the terms of the agreement, Orion will provide Eisai with exclusive rights to market the two products in China. Both drugs were previously marketed in...</description>
      <guid>http://www.orion.fi/en/News-and-media/Actual--page-list/Orion-and-Eisai-into-a-marketing-agreement-in-China/</guid>
      <pubDate>Thu, 14 Jul 2011 09:40:23 GMT</pubDate>
    </item>
    <item>
      <title>100,000 Orion A-shares converted into B-shares</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/19/</link>
      <description>ORION CORPORATION&amp;nbsp; STOCK EXCHANGE RELEASE 22 June 2011&amp;nbsp;at 8.45 a.m. EEST In accordance with Section 3 of the Articles of Association of Orion Corporation, 100,000 A-shares have been converted into 100,000 B-shares. The conversion has been entered into the Trade Register on 22 June 2011. The total number of shares in Orion Corporation is 141,257,828&amp;nbsp; which, after the conversion, consists of...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/19/</guid>
      <pubDate>Wed, 22 Jun 2011 08:49:17 GMT</pubDate>
    </item>
    <item>
      <title>628,914 Orion A-shares converted into B-shares</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/18/</link>
      <description>ORION CORPORATION&amp;nbsp; STOCK EXCHANGE RELEASE 9 June 2011&amp;nbsp; AT 9.20 a.m. EEST In accordance with Section 3 of the Articles of Association of Orion Corporation, 628,914 A-shares have been converted into 628,914 B-shares. The conversion has been entered into the Trade Register on 9 June 2011. The total number of shares in Orion Corporation is 141,257,828&amp;nbsp; which, after the conversion, consists of...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/18/</guid>
      <pubDate>Thu, 09 Jun 2011 09:24:56 GMT</pubDate>
    </item>
    <item>
      <title>173,500 Orion A-shares converted into B-shares</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/17/</link>
      <description>ORION CORPORATION&amp;nbsp; STOCK EXCHANGE RELEASE 5 May 2011&amp;nbsp; AT 8.20 AM EEST In accordance with Section 3 of the Articles of Association of Orion Corporation, 173,500 A-shares have been converted into 173,500&amp;nbsp; B-shares. The conversion has been entered into the Trade Register on 5 May 2011. The total number of shares in Orion Corporation is 141,257,828&amp;nbsp; which, after the conversion, consists of 46,912,7...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/17/</guid>
      <pubDate>Thu, 05 May 2011 08:24:52 GMT</pubDate>
    </item>
    <item>
      <title>Orion Group Interim Report January-March 2011</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/16/</link>
      <description>ORION CORPORATION / INTERIM REPORT / JANUARY-MARCH 2011/ 27 April 2011 at 12.00 p.m. EEST Orion's net sales for January-March 2011 totalled EUR 244 million (EUR 215 million for January-March 2010), up by 14% on the comparative period last year. Net sales excluding the non-recurring payment of EUR 7 million from Endo Pharmaceuticals were up by 10%. ·&amp;nbsp;&amp;nbsp;&amp;nbsp; Operating profit was EUR 93 (71) million....</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/16/</guid>
      <pubDate>Wed, 27 Apr 2011 12:04:53 GMT</pubDate>
    </item>
    <item>
      <title>397,408  Orion A-shares converted into B-shares</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/15/</link>
      <description>ORION CORPORATION&amp;nbsp; STOCK EXCHANGE RELEASE 20 April 2011 AT 9.40 a.m. EEST In accordance with Section 3 of the Articles of Association of Orion Corporation, 397,408 A-shares have been converted into 397,408 B-shares. The conversion has been entered into the Trade Register on 20 April 2011. The total number of shares in Orion Corporation is 141,257,828&amp;nbsp; which, after the conversion, consists of...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/15/</guid>
      <pubDate>Wed, 20 Apr 2011 09:44:54 GMT</pubDate>
    </item>
    <item>
      <title>Orion invites analysts and media to Q1 news conference on Wednesday 27 April 2011</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/14/</link>
      <description>ORION CORPORATION &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; STOCK EXCHANGE RELEASE&amp;nbsp;&amp;nbsp; 18 APRIL at&amp;nbsp;10.35&amp;nbsp;&amp;nbsp;AM EEST &amp;nbsp; Orion will publish its Interim Report January-March 2011 on Wednesday, 27 April 2011 approximately at 12:00 Finnish time (EEST). The release and related presentation material in Finnish and in English will be available on the Group's homepage at www.orion.fi/en promptly after the publishing. &amp;nbsp; News conference for...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/14/</guid>
      <pubDate>Mon, 18 Apr 2011 10:39:52 GMT</pubDate>
    </item>
    <item>
      <title>Orion upgrades full-year outlook for 2011</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/13/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 13 April 2011 at 5.02 p.m. EEST Orion Corporation upgrades the full-year outlook estimate for 2011 provided in the Financial Statement Release 2010 and published on 9 February 2011. The company estimates that well-developed sales in early 2011 will also reflect on the development of full-year operating profit. New full-year outlook estimate for 2011,...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/13/</guid>
      <pubDate>Wed, 13 Apr 2011 17:04:06 GMT</pubDate>
    </item>
    <item>
      <title>Orion Corporation: Organising meeting of the Board of Directors</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/12/</link>
      <description>Orion Corporation&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Stock Exchange Release&amp;nbsp;&amp;nbsp; 31 March 2011&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; at 4.25 p.m. EEST &amp;nbsp; &amp;nbsp; &amp;nbsp; In its organising meeting, the Board of Directors of Orion Corporation, which was elected today by the Annual General Meeting of the Shareholders, has elected Matti Kavetvuo as Vice Chairman. The compositions of the Board committees were decided to be as follows: &amp;nbsp; Remuneration Committee: Hannu Syrjänen...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/12/</guid>
      <pubDate>Thu, 31 Mar 2011 16:29:53 GMT</pubDate>
    </item>
    <item>
      <title>Orion Corporation: Decisions by the AGM on 31 March 2011</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/11/</link>
      <description>Orion Corporation&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Stock Exchange Release&amp;nbsp;&amp;nbsp; 31 March 2011&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; at&amp;nbsp;4.15 p.m. EEST &amp;nbsp; &amp;nbsp; Orion Corporation: Decisions by the AGM on 31 March 2011 &amp;nbsp; At the Annual General Meeting of Orion Corporation held today, the following decisions were made: A dividend of EUR 1.20 per share was confirmed to be paid for 2010. Additionally, EUR 0.06 per share was confirmed to be paid to the shareholders as a...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/11/</guid>
      <pubDate>Thu, 31 Mar 2011 16:18:57 GMT</pubDate>
    </item>
    <item>
      <title>President and CEO Timo Lappalainen today at Annual General Meeting of Orion Corporation: Orion's sales developed well in early 2011  </title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/10/</link>
      <description>ORION CORPORATION STOCK EXCHANGE RELEASE 31 March 2011 at 12.05 p.m. EEST Orion Corporation is holding its Annual General Meeting today, March 31, 2011, at 2.00 p.m. EEST. President and CEO Timo Lappalainen will present a review of Orion's year 2010. In his presentation Mr. Lappalainen will mention that Orion's sales have developed well in early 2011, which indicates a strong result for Q1 2011...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/10/</guid>
      <pubDate>Thu, 31 Mar 2011 12:08:57 GMT</pubDate>
    </item>
    <item>
      <title>Orion’s Well-being lounge has opened on the Internet </title>
      <link>http://www.orion.fi/en/News-and-media/Actual--page-list/Orions-Well-being-lounge-has-opened-on-the-Internet-/</link>
      <description>Orion’s new Well-being lounge has been opened and the 2010 Annual Report has been published on the company’s Internet pages. The Well-being lounge contains a variety of stories, videos, well-being tips and professional articles on the theme of well-being and health. The pages will gain new content throughout the year and will serve to complement Orion’s official annual report, which this year i...</description>
      <guid>http://www.orion.fi/en/News-and-media/Actual--page-list/Orions-Well-being-lounge-has-opened-on-the-Internet-/</guid>
      <pubDate>Thu, 11 Aug 2011 15:49:02 GMT</pubDate>
    </item>
    <item>
      <title>Orion Group Annual Report 2010 published</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/9/</link>
      <description>ORION CORPORATION&amp;nbsp;&amp;nbsp;&amp;nbsp; STOCK EXCHANGE RELEASE&amp;nbsp; 9 March 2011 AT 13.30&amp;nbsp; EET Orion Group's Annual Report 2010, including Financial Statements, is now available in Finnish and English on company's website at http://www.orion.fi/en/News-and-media/Annual-Reports/ This year, Orion will publish its annual report for the first time only as an online report. Printed copies of Financial Statement documents...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/9/</guid>
      <pubDate>Wed, 09 Mar 2011 13:35:02 GMT</pubDate>
    </item>
    <item>
      <title>Subscribe for publications</title>
      <link>http://www.orion.fi/en/News-and-media/Subscribe-for-publications/</link>
      <description>&amp;nbsp; You can subscribe for news releases of the Orion Group by filling in the the form.&amp;nbsp; The form will appear on the screen, if you click the link to the registration form . &amp;nbsp; With the order form you can subscribe for: Stock exchange releases into your e-mailbox Interim Reports into your e-mailbox Printed version of the financial statement documents With the&amp;nbsp;order form you can also: Change your...</description>
      <guid>http://www.orion.fi/en/News-and-media/Subscribe-for-publications/</guid>
      <pubDate>Wed, 09 Mar 2011 08:24:31 GMT</pubDate>
    </item>
    <item>
      <title>Orion Corporation: Transfer of 102,900 own B-shares </title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/8/</link>
      <description>Orion Corporation&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Stock Exchange Release&amp;nbsp;&amp;nbsp; 1 March 2011&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; at&amp;nbsp;6.45 p.m. EET &amp;nbsp; &amp;nbsp; In accordance with a decision by the Board of Directors, Orion Corporation has on 1 March 2011 transferred altogether 102,900 Orion Corporation B-shares held by the company as a share reward for 2010 to the persons employed by the Orion Group and belonging to the Share-based Incentive Plan of the Orion Group...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/8/</guid>
      <pubDate>Tue, 01 Mar 2011 18:49:56 GMT</pubDate>
    </item>
    <item>
      <title>Notice to the Annual General Meeting of Orion Corporation</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/7/</link>
      <description>Orion Corporation&amp;nbsp; Stock Exchange Release&amp;nbsp; 9 February 2011 at&amp;nbsp;1.15 p.m. EET &amp;nbsp; &amp;nbsp; The Board of Directors of Orion Corporation has decided today to convene the Annual General Meeting of the Shareholders of Orion Corporation on 31 March 2011. The Notice to the Meeting will be published in Finnish in the Helsingin Sanomat newspaper on Thursday, 10 February 2011, with the following contents:&amp;nbsp; &amp;nbsp; Notic...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/7/</guid>
      <pubDate>Wed, 09 Feb 2011 13:19:36 GMT</pubDate>
    </item>
    <item>
      <title>Orion Group Financial Statement Release for 2010</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/6/</link>
      <description>ORION CORPORATION FINANCIAL STATEMENT RELEASE 2010&amp;nbsp; 9 FEBRUARY 2011 at 12:00 EET Orion Group Financial Statement Release for 2010 Orion's net sales in 2010 totalled EUR 850 million (EUR 772 million in 2009), up by 10% on the previous year. Operating profit was EUR 254 (207) million. Profit before taxes was EUR 253 (204) million. Equity ratio was 63% (61%). ROCE before taxes was 45% (37%). ROE...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/6/</guid>
      <pubDate>Wed, 09 Feb 2011 12:04:39 GMT</pubDate>
    </item>
    <item>
      <title>Recommendation by the Nomination Committee concerning  Board of Directors to be elected by the 2011 AGM of Orion Corporation</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/5/</link>
      <description>Orion Corporation&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Stock Exchange Release&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 31 Jan 2011&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; at 12.30 p.m. EET The Nomination Committee of Orion Corporation has given its recommendation to the Board of Directors of the company for the proposal to the Annual General Meeting of 2011 concerning the composition of the Board of Directors to be elected. The Committee recommends that the following proposal be presente...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/5/</guid>
      <pubDate>Mon, 31 Jan 2011 12:34:53 GMT</pubDate>
    </item>
    <item>
      <title>Orion Corporation and Endo Pharmaceuticals enter into novel R&amp;D collaboration</title>
      <link>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/15/Orion-Corporation-and-Endo-Pharmaceuticals-enter-into-novel-RD-collaboration/</link>
      <description>Orion Corporation (Nasdaq OMX Helsinki: ORNAV and ORNBV) announced today that it has entered into a collaboration agreement with Endo Pharmaceuticals (Nasdaq: ENDP) for the discovery, development and commercialization of assets in Oncology. The formation of this R&amp;amp;D collaboration partnership allows the companies to bring forward a total of eight “discovery phase” candidates by combining an equa...</description>
      <guid>http://www.orion.fi/en/News-and-media/Press-releases2/Archive/15/Orion-Corporation-and-Endo-Pharmaceuticals-enter-into-novel-RD-collaboration/</guid>
      <pubDate>Fri, 28 Jan 2011 09:25:59 GMT</pubDate>
    </item>
    <item>
      <title>Orion sues Mylan in the U.S. to enforce its U.S. patent covering the proprietary drug Comtan®</title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/4/</link>
      <description>Orion Corporation&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Stock Exchange Release&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 24 Jan 2011&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; at&amp;nbsp; 7.25 p.m. EET &amp;nbsp; Company states generic competition is not imminent &amp;nbsp; Orion Corporation has filed a patent infringement lawsuit in the United States to enforce Orion's U.S. patent No. 5,446,194 covering Comtan ® against Mylan Pharmaceuticals Inc. (Mylan). Mylan seeks authorisation to produce and market a generic...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/4/</guid>
      <pubDate>Mon, 24 Jan 2011 19:29:53 GMT</pubDate>
    </item>
    <item>
      <title>Orion invites analysts and media to Financial Statement Release conference on Wednesday 9 February 2011 </title>
      <link>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/3/</link>
      <description>ORION CORPORATION &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; STOCK EXCHANGE RELEASE&amp;nbsp;&amp;nbsp; 20 JANUARY 2011 at 9.45 AM EET Orion will publish its Financial Statement Release for 2010 on Wednesday, 9 February 2011 approximately at 12:00 Finnish time (EET). The release and related presentation material in Finnish and in English will be available on the Group's homepage at www.orion.fi/en promptly after the publishing. News conference for...</description>
      <guid>http://www.orion.fi/en/News-and-media/Stock-exchange-releases/Archive/2011/3/</guid>
      <pubDate>Thu, 20 Jan 2011 09:48:23 GMT</pubDate>
    </item>
  </channel>
</rss>
